BROADWOOD PARTNERS, L.P. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

BROADWOOD PARTNERS, L.P. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $91.70M. Historical track record: 4/5 stars across 28 tracked purchases.

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating★★★★☆ (4/5)
Total purchases tracked28
Purchases with forward-return data27
30-day win rate5185%
90-day win rate4815%
Avg 5-day return-99.91%
Avg 30-day return+493.83%
Avg 90-day return-77.37%
Best 30-day return+4971.69%

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-04-27IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase0$0.00
2026-04-27IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase250.9K$3.64$913K
2026-04-27IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase0$0.00
2026-04-27IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase38.9K$3.53$137K
2026-04-27IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase0$0.00
2026-04-27IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase280.4K$3.50$982K
2026-04-20IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase0$0.00
2026-04-20IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase40.7K$3.88$158K
2026-04-20IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase0$0.00
2026-04-20IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase40.1K$3.57$143K
2026-04-20IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase0$0.00
2026-04-20IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase102.1K$3.45$352K
2026-03-13STAASTAAR SURGICAL COP — Open-market purchase0$0.00
2026-03-13STAASTAAR SURGICAL COP — Open-market purchase316.0K$18.61$5.88M
2026-03-13STAASTAAR SURGICAL COP — Open-market purchase0$0.00
2026-03-13STAASTAAR SURGICAL COP — Open-market purchase299.4K$18.12$5.42M
2026-03-13STAASTAAR SURGICAL COP — Open-market purchase0$0.00
2026-03-13STAASTAAR SURGICAL COP — Open-market purchase54.8K$17.52$960K
2026-02-13IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase0$0.00
2026-02-13IMDXInsight Molecular Diagnostics Inc.P — Open-market purchase521.7K$5.75$3.00M

Companies — Last 90 Days

Frequently Asked Questions

Who is BROADWOOD PARTNERS, L.P.?

BROADWOOD PARTNERS, L.P. is a corporate insider — currently tracked as 10% Owner of Insight Molecular Diagnostics Inc. (IMDX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has BROADWOOD PARTNERS, L.P. submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has BROADWOOD PARTNERS, L.P. been buying or selling stock?

Recorded transactions: 68 open-market purchases ($91.70M) and 0 open-market sales () across all tracked filings.

How accurate is BROADWOOD PARTNERS, L.P.'s historical track record?

Across 28 tracked purchases, BROADWOOD PARTNERS, L.P. averaged +493.8% avg 30-day return with a 5185% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.

Where can I see all of BROADWOOD PARTNERS, L.P.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live BROADWOOD PARTNERS, L.P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.